Free Trial

Xeris Biopharma (XERS) SEC Filings & 10K Form

Xeris Biopharma logo
$3.75 -0.22 (-5.54%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$3.76 +0.00 (+0.13%)
As of 02/21/2025 07:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Xeris Biopharma SEC Filings

DateFilerForm TypeView
02/03/2025
6:39 PM
JOHNSON KENNETH ERLAND (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:39 PM
Pieper Steven (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:39 PM
Hecht Beth (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:40 PM
Shannon John Patrick Jr (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:40 PM
McCulloch Kevin (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
6:17 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:40 PM
Hecht Beth (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:42 PM
Pieper Steven (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:42 PM
JOHNSON KENNETH ERLAND (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:42 PM
McCulloch Kevin (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:43 PM
Shannon John Patrick Jr (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
4:00 PM
Pieper Steven (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
6:13 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:15 PM
Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
5:28 PM
Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
3:27 PM
Xeris Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2024
6:15 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
4:22 PM
McCulloch Kevin (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
4:22 PM
Shannon John Patrick Jr (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
6:14 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:15 PM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2024
3:18 PM
HALKUFF DAWN (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:18 PM
Kong Garheng (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:18 PM
PERSKY MARLA (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:18 PM
JOHNSON JOHN (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:19 PM
BORMANN-KENNEDY BARBARA-JEAN ANNE (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:19 PM
SHERMAN JEFFREY W (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:19 PM
Fairley Ricki Louise (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
3:19 PM
Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
3:19 PM
Xeris Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:14 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
3:32 PM
Xeris Biopharma (Filer)
Form ARS
04/23/2024
3:24 PM
Xeris Biopharma (Filer)
Form DEF 14A
04/23/2024
3:26 PM
Xeris Biopharma (Filer)
Form DEFA14A
04/11/2024
3:05 PM
SHERMAN JEFFREY W (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
4:43 PM
JOHNSON JOHN (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
4:45 PM
Kong Garheng (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2024
4:32 PM
JOHNSON JOHN (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
8:03 PM
Schmid John P. (Reporting)
Xeris Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:19 PM
Xeris Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2024
6:27 AM
Xeris Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Watch This Robotics Demo Before March 17th (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:XERS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners